New mRNA vaccine shows promise against childhood cancer
New mRNA vaccine shows promise against childhood cancer
Updated at: June 21, 2026 at 01:45 AM
Recent advancements in mRNA technology, famously used in COVID-19 vaccines, are now being harnessed to fight childhood cancer.
Unlike traditional vaccines used for prevention, these therapeutic vaccines aim to 're-educate' the immune system to recognize and eliminate malignant cells that have previously evaded detection.
For neuroblastoma, a highly aggressive cancer, scientists have developed a vaccine using self-assembling nanoparticles.
Meanwhile, a groundbreaking clinical trial is launching in Australia to test personalized mRNA vaccines for children with brain cancer.
Because every tumor is unique, each vaccine is custom-made for the individual patient, aiming to activate their immune system to fight their specific cancer.
By offering a more precise alternative to conventional chemotherapy and radiation, this technology seeks to improve survival rates while minimizing the harsh side effects that often impact childhood cancer survivors.
